Short answer · Medically reviewed summary · Last updated: 2023-07-13
Multiminicore myopathy is a rare genetic disorder that affects skeletal muscles, causing muscle weakness and potential respiratory complications. It is classified as a subtype of congenital myopathy, a group of inherited muscle disorders.
What is the prevalence of Multiminicore Myopathy?
Prevalence of Multiminicore Myopathy: how many people are affected worldwide, differences by sex and region, with sources.
Multiminicore myopathy is a rare genetic disorder that affects skeletal muscles, causing muscle weakness and potential respiratory complications. It is classified as a subtype of congenital myopathy, a group of inherited muscle disorders. The prevalence of multiminicore myopathy is estimated to be around 1 in 100,000 individuals, making it a relatively uncommon condition.
The disorder is typically diagnosed in childhood or adolescence, although the severity and progression of symptoms can vary widely among affected individuals. Common symptoms include muscle weakness, delayed motor development, joint contractures, and scoliosis. In severe cases, respiratory complications may arise due to weakness in the muscles involved in breathing.
While the exact cause of multiminicore myopathy is not fully understood, it is believed to be associated with mutations in certain genes involved in muscle function. Genetic testing can help confirm the diagnosis.
Although multiminicore myopathy is a rare condition, ongoing research and advancements in genetic testing have improved our understanding of the disorder. Early diagnosis and appropriate management can help individuals with multiminicore myopathy lead fulfilling lives and receive necessary support.
